SERB completes acquisition of BTG Specialty Pharmaceuticals to create a global leader in critical care medicines

Choose a product for orders or supply-related questions

Australia

DigiFab

Tel: +61 (0)2 9420 9199 or 1800 720 020

Fax: +61 (0)2 9420 9177 or 1800 100 013

Email: orders@phebra.com

In all other territories, for general supply-related questions, please contact

productsupplies@btgsp.com

General Contact Details

AE / Complaint Reporting

To report a suspected adverse event associated with any of our products, please contact:

Tel: +1 877-377-3784

Email: Vigilance@btgsp.com

Medical Information

For medical information on any of our Pharmaceutical products, please contact:

Tel (US): +1 877 377 3784 (24hrs/7days)
Tel (Outside US): +1-303-389-1204 (24hrs/7days)
Email: btgpharmamedicalinfo@btgsp.com 

 

Ethics and Compliance

For all ethics and compliance enquires please contact:

Tel: +1 610 943 3505

Email: compliance@btgsp.com

Media Contacts

Chris Sampson, Director Corporate Communications

Tel: +44 7773 251 178

Email: chris.sampson@btgsp.com

Human Resources

For HR enquiries please contact:

Email: hr@btgsp.com

Our Locations

BTG Australasia

Pharmaceuticals manufacturing

Australia Office

BTG Australasia Pty Ltd,RSD Turretfield RC, 129 Holland Road,Rosedale

Australia

Tel: +61 (0)8 8524 9700

Fax: +61 (0)8 8524 9113

BTG Philadelphia

Corporate and commercial functions

USA Office

BTG International Inc.,300 Four Falls Corporate Center, Suite 300, 300 Conshohocken State Road,West Conshohocken, Pennsylvania

19428

United States of America

Tel: +1 610 943 6000

Fax: +1 610 943 6018

BTG Wales

Pharmaceuticals manufacturing

UK Office

Protherics UK Ltd,Blaenwaun, Ffostrasol, Llandysul,Ceredigion

SA44 5JT

United Kingdom

Tel: +44 (0)1239 851122